Prehypertension: risk stratification and management considerations (Q37262225)

19 August 2017

1 reference

title

Prehypertension: risk stratification and management considerations (English)

1 reference

19 August 2017

Brent M Egan

1

1 reference

PubMed ID

18775112

19 August 2017

Stevo Julius

series ordinal

2

1 reference

19 August 2017

1 October 2008

1 reference

Current Hypertension Reports

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

5

1 reference

19 August 2017

359-366

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-008-0068-0

19 August 2017

0 references

cites work

High-normal blood pressure progression to hypertension in the Framingham Heart Study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-008-0068-0

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-008-0068-0

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-008-0068-0

Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

12 December 2020

Feasibility of treating prehypertension with an angiotensin-receptor blocker

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

12 December 2020

Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

1 reference

12 December 2020

Smoking and diet intervention in healthy coronary high risk men. Methods and 5-year follow-up of risk factors in a randomized trial. The Oslo study

1 reference

12 December 2020

Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study

1 reference

12 December 2020

Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden

1 reference

12 December 2020

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

1 reference

12 December 2020

Borderline hypertension--a critical review

1 reference

12 December 2020

Prehypertension and cardiovascular disease risk in the Women's Health Initiative

1 reference

12 December 2020

Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients

1 reference

12 December 2020

Endothelium-dependent vasodilation in normotensive subjects with a familial history of essential hypertension and in young subjects with borderline hypertension

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.

1 reference

12 December 2020

Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

1 reference

12 December 2020

Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collab

1 reference

12 December 2020

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients

1 reference

12 December 2020

The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study.

1 reference

12 December 2020

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

1 reference

12 December 2020

TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension.

1 reference

12 December 2020

From "prehypertension" to hypertension? Additional evidence.

1 reference

12 December 2020

Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

1 reference

12 December 2020

A decade of progress in the management of hypertension

1 reference

12 December 2020

Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study

1 reference

12 December 2020

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

1 reference

12 December 2020

Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000.

1 reference

12 December 2020

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

1 reference

12 December 2020

Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension

1 reference

12 December 2020

Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study

1 reference

12 December 2020

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

12 December 2020

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Expanding the definition and classification of hypertension.

1 reference

12 December 2020

Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease

1 reference

12 December 2020

Prehypertension and cardiovascular morbidity.

1 reference

12 December 2020

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

12 December 2020

Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

10.1007/S11906-008-0068-0

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18775112